KRAS Inhibitors

KRAS is one of the earliest discovered driver genes in cancer, with frequent mutations observed in lung, pancreatic, and colorectal cancers. Mutations in KRAS (such as G12C, G12D) lead to its continuous activation, driving uncontrolled cell proliferation, making it a key therapeutic target. Despite its discovery in the 1980s, KRAS was long considered "undruggable" due to the lack of a suitable binding site. In 2013, researchers discovered that the KRAS G12C mutation forms a "switch-II" pocket that can be targeted by covalent inhibitors, paving the way for KRAS-targeted drug development. Amgen and Mirati developed Sotorasib (Lumakras) and Adagrasib (Krazati), which were approved in 2021 and 2022, marking a new era in KRAS-targeted therapy. As research advances, drug development is expanding to target more challenging KRAS mutations like G12D, combining other therapeutic mechanisms (such as SHP2, EGFR inhibitors, or immunotherapy) to improve efficacy. For example, the novel drug RMC-6236 induces the formation of complexes between CypA and various RAS(ON) mutant proteins, inhibiting tumor growth and offering an innovative treatment approach. The development of KRAS-targeted drugs breaks the "undruggable" barrier, signaling a paradigm shift towards precision therapy. AMbeed offers a range of KRAS inhibitors, especially milestone novel KRAS inhibitors, to meet your research needs.

KRAS Inhibitors

RMC-6236
click to sign in and save

A17277012765081-21-699%

RMC-6236

$421.00/100mg Detail

RMC-9805
click to sign in and save

A24798832922732-54-398%

RMC-9805

$94.00/1mg Detail

MRTX1133
click to sign in and save

A15012702621928-55-898% LC

MRTX1133

$105.00/5mg Detail

Sotorasib
click to sign in and save

A11550002296729-00-398%

Sotorasib

$86.00/100mg Detail

Adagrasib
click to sign in and save

A11923322326521-71-398%

Adagrasib

$58.00/2mg Detail

Lonafarnib
click to sign in and save

A257211193275-84-298%

Lonafarnib

$119.00/10mg Detail

LC-2
click to sign in and save

A13259612502156-03-698%

LC-2

$235.00/5mg Detail

BI-3406
click to sign in and save

A11771572230836-55-098%

BI-3406

$1199.00/1g Detail

Divarasib
click to sign in and save

A16009722417987-45-098%

Divarasib

$1595.00/250mg Detail

BAY-293
click to sign in and save

A11672682244904-70-798%

BAY-293

$155.00/25mg Detail

BI-2852
click to sign in and save

A11664732375482-51-098%

BI-2852

$335.00/5mg Detail

RMC-7977
click to sign in and save

A26283122765082-12-898%

RMC-7977

$896.00/100mg Detail

ARS-853
click to sign in and save

A5020821629268-00-398%

ARS-853

$87.00/5mg Detail

BI-2865
click to sign in and save

A22619172937327-93-899%

BI-2865

$1212.00/50mg Detail

Glecirasib
click to sign in and save

A24172482657613-87-998%

Glecirasib

$111.00/5mg Detail

AZD4747
click to sign in and save

A26685042489226-14-299%

AZD4747

$1234.00/25mg Detail

Opnurasib
click to sign in and save

A15495412653994-08-098%

Opnurasib

$1646.00/50mg Detail

RMC-6291
click to sign in and save

A20202012641998-63-098%

RMC-6291

$169.00/1mg Detail

RMC-4998
click to sign in and save

A24174452642037-07-697%

RMC-4998

$120.00/10mg Detail

MRTX-1257
click to sign in and save

A10035712206736-04-998%

MRTX-1257

$43.00/1mg Detail

1 2 3 4    page 1 of 4 Pages